SCHEMBL28023995

SCHEMBL28023995

CCN1CCN(Cc2ccc(Nc3cc(NC(=O)Nc4c(Cl)cc(Cl)cc4Cl)ncn3)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 7/20 0.50
EGFR P00533 6/20 0.50
RAB9A P51151 5/20 0.50
NPC1 O15118 4/20 0.50
TP53 P04637 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
ABL1 P00519 3/20 0.50
KIT P10721 3/20 0.50
SRC P12931 3/20 0.50
BRAF P15056 3/20 0.50
KDR P35968 3/20 0.50
TEK Q02763 3/20 0.50
POLB P06746 1/20 0.50
PDGFRB P09619 1/20 0.50
EPHB4 P54760 1/20 0.50
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
FGFR3 P22607 7/20 0.47
ALOX15 P16050 2/20 0.45
CYP2C9 P11712 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL373374 0.92 FGFR3 (0.56) FGFR1EGFRABL1KITSRC
SCHEMBL28023618 0.92 FGFR1 (0.59) FGFR1EGFRRAB9ANPC1TP53
SCHEMBL28821018 0.88 ABL1 (0.49) FGFR1EGFRABL1KITSRC
SCHEMBL374657 0.85 FGFR3 (0.58) FGFR1EGFRABL1KITSRC
SCHEMBL374228 0.80 LCK (0.57) FGFR1EGFRABL1KITSRC
SCHEMBL373147 0.78 FGFR3 (0.73) EGFRRAB9AFGFR3JAK2LCK
SCHEMBL15295501 0.78 FGFR3 (0.59) FGFR1EGFRABL1KITSRC
SCHEMBL374474 0.78 METTL3 (0.47) FGFR1EGFRRAB9ANPC1TP53
SCHEMBL374470 0.77 FGFR3 (0.56) FGFR1EGFRABL1KITSRC
SCHEMBL374703 0.75 FGFR3 (0.75) FGFR1EGFRABL1KITSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103121972-B As the pyrimidine urea derivatives of kinase inhibitor NOVARTIS AG (CH) 2015-07-29 CN claimed